233 related articles for article (PubMed ID: 18355507)
1. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study.
Mentzer RM; Bartels C; Bolli R; Boyce S; Buckberg GD; Chaitman B; Haverich A; Knight J; Menasché P; Myers ML; Nicolau J; Simoons M; Thulin L; Weisel RD;
Ann Thorac Surg; 2008 Apr; 85(4):1261-70. PubMed ID: 18355507
[TBL] [Abstract][Full Text] [Related]
2. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study.
Boyce SW; Bartels C; Bolli R; Chaitman B; Chen JC; Chi E; Jessel A; Kereiakes D; Knight J; Thulin L; Theroux P;
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):420-7. PubMed ID: 12928639
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft surgery.
Weber W; Harnisch L; Jessel A;
Clin Pharmacol Ther; 2002 Jun; 71(6):457-67. PubMed ID: 12087349
[TBL] [Abstract][Full Text] [Related]
4. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
Whellan DJ; Tricoci P; Chen E; Huang Z; Leibowitz D; Vranckx P; Marhefka GD; Held C; Nicolau JC; Storey RF; Ruzyllo W; Huber K; Sinnaeve P; Weiss AT; Dery JP; Moliterno DJ; Van de Werf F; Aylward PE; White HD; Armstrong PW; Wallentin L; Strony J; Harrington RA; Mahaffey KW
J Am Coll Cardiol; 2014 Mar; 63(11):1048-57. PubMed ID: 24211500
[TBL] [Abstract][Full Text] [Related]
5. Na+/H+ exchange inhibitor cariporide attenuates skeletal muscle infarction when administered before ischemia or reperfusion.
McAllister SE; Moses MA; Jindal K; Ashrafpour H; Cahoon NJ; Huang N; Neligan PC; Forrest CR; Lipa JE; Pang CY
J Appl Physiol (1985); 2009 Jan; 106(1):20-8. PubMed ID: 19023020
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.
Théroux P; Chaitman BR; Danchin N; Erhardt L; Meinertz T; Schroeder JS; Tognoni G; White HD; Willerson JT; Jessel A
Circulation; 2000 Dec; 102(25):3032-8. PubMed ID: 11120691
[TBL] [Abstract][Full Text] [Related]
7. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
[TBL] [Abstract][Full Text] [Related]
8. The Na+/H+ exchange inhibitor cariporide is washed out of the myocardium by crystalloid cardioplegia.
Bechtel JF; Eichler W; Toerber K; Weidtmann B; Hernandez M; Klotz KF; Sievers HH; Bartels C
Thorac Cardiovasc Surg; 2006 Aug; 54(5):317-23. PubMed ID: 16902879
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic treatment with the sodium hydrogen exchanger 1 (NHE-1) inhibitor cariporide on myocardial infarct mass in rabbits with hypercholesterolaemia.
Jung O; Albus U; Lang HJ; Busch AE; Linz W
Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):24-30. PubMed ID: 15245573
[TBL] [Abstract][Full Text] [Related]
10. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
[TBL] [Abstract][Full Text] [Related]
11. GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes.
Erhardt LR
Am J Cardiol; 1999 May; 83(10A):23G-25G. PubMed ID: 10482177
[TBL] [Abstract][Full Text] [Related]
12. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery.
Chello M; Anselmi A; Spadaccio C; Patti G; Goffredo C; Di Sciascio G; Covino E
Ann Thorac Surg; 2007 Apr; 83(4):1374-80. PubMed ID: 17383342
[TBL] [Abstract][Full Text] [Related]
14. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
Wang P; Zaragoza C; Holman W
Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of zoniporide, an Na/H exchange ion inhibitor, for reducing perioperative cardiovascular events in vascular surgery patients.
Fleisher LA; Newman MF; St Aubin LB; Cropp AB; Billing CB; Bonney S; Mackey WC; Poldermans D; Corbalan R; Pereira AH; Coriat P;
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):570-6. PubMed ID: 16202888
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide.
Fujii M; Avkiran M; Chambers DJ
Ann Thorac Surg; 2004 Apr; 77(4):1398-407. PubMed ID: 15063274
[TBL] [Abstract][Full Text] [Related]
17. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.
; Alexander JH; Emery RW; Carrier M; Ellis SJ; Mehta RH; Hasselblad V; Menasche P; Khalil A; Cote R; Bennett-Guerrero E; Mack MJ; Schuler G; Harrington RA; Tardif JC
JAMA; 2008 Apr; 299(15):1777-87. PubMed ID: 18381567
[TBL] [Abstract][Full Text] [Related]
19. Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide.
Chang HB; Gao X; Nepomuceno R; Hu S; Sun D
Exp Neurol; 2015 Oct; 272():11-6. PubMed ID: 25595121
[TBL] [Abstract][Full Text] [Related]
20. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
Verrier ED; Shernan SK; Taylor KM; Van de Werf F; Newman MF; Chen JC; Carrier M; Haverich A; Malloy KJ; Adams PX; Todaro TG; Mojcik CF; Rollins SA; Levy JH;
JAMA; 2004 May; 291(19):2319-27. PubMed ID: 15150203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
